Skip to main content

Packaging, labeling and serialization

๐Ÿ“ Where we are: Part 19 of the journey โ€” the medicine is sealed in vials, and now we turn it into a finished, trackable package.

By now the medicine is inside sealed glass vials or syringes. But a bare vial cannot be shipped to a hospital. In this step we inspect each vial, add a label, box it with instructions, and give every single pack its own unique code so it can be tracked all the way to the patient.

The simple version

Think of how every passport has a photo, a name, and a number that no one else has. Here we give every single package of medicine its own "passport": a label that says what it is, and a unique barcode that lets anyone follow that exact pack from the factory to the pharmacy shelf.

What actually happensโ€‹

The sealed vials arrive from fill-finish, and now they become a real, shippable product.

  1. Inspection. Every vial is checked, often by a fast camera system and sometimes by a trained human eye. The machine looks for cracks in the glass, a wrong fill level, or tiny floating particles. A protein medicine should be clear. Anything that looks off is rejected. This protects the patient from a damaged or contaminated dose.
  2. Labeling. A label is printed and applied to each vial. It carries the product name, the strength (how much medicine is inside), the lot number (a code identifying which batch it came from), and the expiry date (the last day it is safe to use).
  3. Secondary packaging. Vials go into a carton along with the patient leaflet โ€” the printed instructions on how to use the medicine and what side effects to watch for.
  4. Serialization. A unique, machine-readable code is printed on each carton. This is usually a 2D data matrix (a small square barcode that holds a lot of information). No two packs share the same code.
  5. Cold-chain prep. Many biologics must stay cold, often at 2 to 8 ยฐC. Here the packs are placed into insulated shippers with cooling packs and a temperature indicator โ€” a small tag that changes if the box ever got too warm.

Why it mattersโ€‹

Serialization exists to solve two real-world dangers.

The first is counterfeit medicine โ€” fake products made by criminals, which may contain the wrong dose or no medicine at all. Because every genuine pack has a unique code that pharmacies and authorities can verify, a fake pack with a copied or missing code can be caught before it reaches anyone.

The second is the recall. If a problem is later found in one batch, the lot number and serial codes let the company find exactly which packs are affected and pull only those โ€” not every box in the country. That precision saves time and keeps the medicine flowing to patients who need it.

A wrong label is just as dangerous as a wrong medicine. The right name, strength, and expiry date are how a nurse trusts the dose they are about to give.

In the real worldโ€‹

This unit-by-unit tracking is not optional โ€” it is the law in major markets. In the United States it is required by the DSCSA (Drug Supply Chain Security Act). In Europe it is the Falsified Medicines Directive. These laws push the whole industry toward an end-to-end digital record, where a pack can be scanned and verified at every handoff from factory to pharmacy. This is part of the larger move toward connected, data-rich manufacturing that modern initiatives, including the U.S. NIIMBL institute, are helping to advance.

Key termsโ€‹

  • Inspection โ€” checking each vial for cracks, particles, or wrong fill level before it ships.
  • Lot number โ€” a code that identifies exactly which batch a pack came from.
  • Expiry date โ€” the last day the medicine is guaranteed safe and effective.
  • Secondary packaging โ€” the carton and patient leaflet placed around the vial.
  • Serialization โ€” printing a unique machine-readable code on each pack so it can be tracked individually.
  • 2D data matrix โ€” a small square barcode that stores the pack's unique identity.
  • Recall โ€” pulling specific affected packs back out of the supply chain when a problem is found.
  • Cold chain โ€” keeping the medicine within a safe temperature range, often 2 to 8 ยฐC, all the way to the patient.